• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左心室致密化不全患者的左心房直径与血栓栓塞风险

Left Atrial Diameter and the Risk of Thromboembolism in Patients with Left Ventricular Noncompaction.

作者信息

Xu Wei, Yang Yanmin, Zhu Jun, Tan Jiangshan, Wang Jingyang, Wang Lulu

机构信息

Emergency Center, State Key Laboratory of Cardiovascular Disease of China, National Clinical Research Center of Cardiovascular Diseases, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.

出版信息

J Cardiovasc Dev Dis. 2022 Nov 30;9(12):426. doi: 10.3390/jcdd9120426.

DOI:10.3390/jcdd9120426
PMID:36547423
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9788599/
Abstract

Aims: Patients with left ventricular noncompaction (LVNC) are at risk of thromboembolism. The relationship between left atrial diameter (LAD), a robust predictor for thrombosis, and LVNC is unclear. The purpose of this study was to explore the effect of LAD on the thrombotic risk in LVNC. Methods: In this retrospective cohort study, 320 patients with imaging characteristics of LVNC were included for statistical analysis. The primary endpoint was a composite event of intracardiac thrombi and stroke or transient ischemic attack (TIA). The secondary endpoints were intracardiac thrombi and stroke/TIA. Results: The 320 included patients (211 [65.9%] men, median age: 45 years [interquartile range: 30−57]) were divided into LAD1 (<43 mm, n = 157) and LAD2 (≥43 mm, n = 163) groups based on the median LAD. Throughout the median follow-up of 34 months, the incidence of thromboembolism among them was 7.2%: 11 (3.4%) patients had stroke/TIA and 14 (4.4%) had intracardiac thrombi. The rate of thromboembolism in the LAD2 group was higher than that of patients in the LAD1 group (11.0% vs. 3.2%, p = 0.007). Kaplan−Meier survival curves suggested that a LAD ≥ 43 mm was associated with a higher risk of thromboembolism and intracardiac thrombi (log-rank test, all p < 0.05). After adjusting for potential risk factors, LAD ≥ 43 mm was found to be an independent risk factor for thromboembolism (p = 0.013) and stroke (p = 0.024). The area under the receiver operating characteristic curve of LAD for predicting thromboembolism reached 0.696 at 1 year, 0.635 at 2 years, and 0.660 at 3 years. Conclusions: A larger LAD was related to a higher risk of thromboembolism in patients with LVNC. The LAD may be a useful predictor for thrombotic risk stratification among such patients.

摘要

目的

左心室心肌致密化不全(LVNC)患者存在血栓栓塞风险。左心房直径(LAD)作为血栓形成的有力预测指标,与LVNC之间的关系尚不清楚。本研究旨在探讨LAD对LVNC患者血栓形成风险的影响。方法:在这项回顾性队列研究中,纳入320例具有LVNC影像学特征的患者进行统计分析。主要终点是心内血栓形成以及中风或短暂性脑缺血发作(TIA)的复合事件。次要终点是心内血栓形成以及中风/TIA。结果:纳入的320例患者(211例[65.9%]为男性,中位年龄:45岁[四分位间距:30 - 57岁])根据LAD中位数分为LAD1组(<43 mm,n = 157)和LAD2组(≥43 mm,n = 163)。在34个月的中位随访期内,他们的血栓栓塞发生率为7.2%:11例(3.4%)患者发生中风/TIA,14例(4.4%)患者有心内血栓形成。LAD2组的血栓栓塞发生率高于LAD1组(11.0%对3.2%,p = 0.007)。Kaplan - Meier生存曲线表明,LAD≥43 mm与更高的血栓栓塞和心内血栓形成风险相关(对数秩检验,所有p < 0.05)。在对潜在危险因素进行校正后,发现LAD≥43 mm是血栓栓塞(p = 0.013)和中风(p = 0.024)的独立危险因素。LAD预测血栓栓塞的受试者工作特征曲线下面积在1年时达到0.696,2年时为0.635,3年时为0.660。结论:更大的LAD与LVNC患者更高的血栓栓塞风险相关。LAD可能是此类患者血栓形成风险分层的有用预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/996e/9788599/ea17ce25f29b/jcdd-09-00426-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/996e/9788599/4489c4f80534/jcdd-09-00426-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/996e/9788599/7c5c56d2e0a5/jcdd-09-00426-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/996e/9788599/ed14869c7151/jcdd-09-00426-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/996e/9788599/9ef88e295a78/jcdd-09-00426-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/996e/9788599/ea17ce25f29b/jcdd-09-00426-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/996e/9788599/4489c4f80534/jcdd-09-00426-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/996e/9788599/7c5c56d2e0a5/jcdd-09-00426-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/996e/9788599/ed14869c7151/jcdd-09-00426-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/996e/9788599/9ef88e295a78/jcdd-09-00426-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/996e/9788599/ea17ce25f29b/jcdd-09-00426-g005.jpg

相似文献

1
Left Atrial Diameter and the Risk of Thromboembolism in Patients with Left Ventricular Noncompaction.左心室致密化不全患者的左心房直径与血栓栓塞风险
J Cardiovasc Dev Dis. 2022 Nov 30;9(12):426. doi: 10.3390/jcdd9120426.
2
Value of left atrial diameter with CHA2DS2-VASc score in predicting left atrial/left atrial appendage thrombosis in non-valvular atrial fibrillation.左房直径联合 CHA2DS2-VASc 评分预测非瓣膜性心房颤动患者左房/左心耳血栓的价值。
Arq Bras Cardiol. 2021 Feb;116(2):325-331. doi: 10.36660/abc.20190492.
3
Prognostic Value of Left Atrial Reservoir Strain in Left Ventricular Myocardial Noncompaction: A 3.0 T Cardiac Magnetic Resonance Feature Tracking Study.左心房储备应变在左心室心肌致密化不全中的预后价值:一项3.0 T心脏磁共振特征追踪研究
J Magn Reson Imaging. 2023 Feb;57(2):559-575. doi: 10.1002/jmri.28292. Epub 2022 Jun 15.
4
Left atrial size and risk of recurrent ischemic stroke in cardiogenic cerebral embolism.左心房大小与心源性脑栓塞复发性缺血性卒中的风险。
Brain Behav. 2020 Oct;10(10):e01798. doi: 10.1002/brb3.1798. Epub 2020 Aug 12.
5
Comparison of cardiovascular magnetic resonance characteristics and clinical prognosis in left ventricular noncompaction patients with and without arrhythmia.比较伴有和不伴有心律失常的左心室心肌致密化不全患者的心血管磁共振特征和临床预后。
BMC Cardiovasc Disord. 2022 Feb 2;22(1):25. doi: 10.1186/s12872-022-02470-7.
6
Cardiac Emerinopathy: A Nonsyndromic Nuclear Envelopathy With Increased Risk of Thromboembolic Stroke Due to Progressive Atrial Standstill and Left Ventricular Noncompaction.心肌性弹力蛋白病:一种非综合征性核膜病,由于进行性房性静止和左心室致密化不全,增加了血栓栓塞性卒中的风险。
Circ Arrhythm Electrophysiol. 2020 Oct;13(10):e008712. doi: 10.1161/CIRCEP.120.008712. Epub 2020 Jul 29.
7
Left Ventricular Noncompaction Cardiomyopathy: Left Ventricular Dilation and Dysfunction at Baseline Portend the Risk of Death or Heart Transplantation.左心室心肌致密化不全心肌病:左心室扩张和功能障碍预示着死亡或心脏移植的风险。
Can J Cardiol. 2022 Jun;38(6):754-762. doi: 10.1016/j.cjca.2022.01.030. Epub 2022 Feb 3.
8
Prognostic Significance of Left Ventricular Noncompaction: Systematic Review and Meta-Analysis of Observational Studies.左心室心肌致密化不全的预后意义:观察性研究的系统评价和荟萃分析。
Circ Cardiovasc Imaging. 2020 Jan;13(1):e009712. doi: 10.1161/CIRCIMAGING.119.009712. Epub 2020 Jan 21.
9
Association of left ventricular abnormalities with incident cerebrovascular events and sources of thromboembolism in patients with chronic Chagas cardiomyopathy.慢性恰加斯心肌病患者左心室异常与脑血管事件及血栓栓塞源的关系。
J Cardiovasc Magn Reson. 2022 Nov 3;24(1):52. doi: 10.1186/s12968-022-00885-x.
10
[Efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and hypertrophic cardiomyopathy].非维生素K拮抗剂口服抗凝药在心房颤动合并肥厚型心肌病患者中的疗效与安全性
Zhonghua Xin Xue Guan Bing Za Zhi. 2022 Jan 24;50(1):62-67. doi: 10.3760/cma.j.cn112148-20210311-00216.

引用本文的文献

1
Myocardial Mechanics and Associated Valvular and Vascular Abnormalities in Left Ventricular Noncompaction Cardiomyopathy.左心室心肌致密化不全心肌病的心肌力学及相关瓣膜和血管异常
J Clin Med. 2023 Dec 22;13(1):78. doi: 10.3390/jcm13010078.

本文引用的文献

1
Clinical impact of left atrial enlargement in Korean patients with atrial fibrillation.韩国房颤患者左心房扩大的临床影响。
Sci Rep. 2021 Dec 10;11(1):23808. doi: 10.1038/s41598-021-03266-z.
2
Anticoagulation in cardiomyopathy: unravelling the hidden threat and challenging the threat individually.心肌病的抗凝治疗:揭示潜在威胁并个体化应对威胁。
ESC Heart Fail. 2021 Dec;8(6):4737-4750. doi: 10.1002/ehf2.13597. Epub 2021 Sep 8.
3
Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction.左心室心肌致密化不全患者的临床风险预测。
J Am Coll Cardiol. 2021 Aug 17;78(7):643-662. doi: 10.1016/j.jacc.2021.06.016.
4
Long-Term Survival of Patients With Left Ventricular Noncompaction.左心室心肌致密化不全患者的长期生存情况。
J Am Heart Assoc. 2021 Jan 19;10(2):e015563. doi: 10.1161/JAHA.119.015563. Epub 2021 Jan 14.
5
Impact of left atrial diameter on outcome in patients undergoing edge-to-edge mitral valve repair: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) registry.经皮缘对缘二尖瓣修复术后左心房直径对患者预后的影响:来自德国经导管二尖瓣介入治疗(TRAMI)注册研究的结果。
Eur J Heart Fail. 2020 Jul;22(7):1202-1210. doi: 10.1002/ejhf.1820. Epub 2020 Apr 4.
6
Clinical and genetic insights into non-compaction: a meta-analysis and systematic review on 7598 individuals.非致密化心肌病的临床和遗传学研究进展:一项基于 7598 例个体的荟萃分析和系统综述
Clin Res Cardiol. 2019 Nov;108(11):1297-1308. doi: 10.1007/s00392-019-01465-3. Epub 2019 Apr 12.
7
Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment.左心房容积与射血分数降低性心力衰竭患者的心血管结局:抗栓治疗的影响。
ESC Heart Fail. 2018 Oct;5(5):800-808. doi: 10.1002/ehf2.12331. Epub 2018 Jul 17.
8
Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis.左心房容积可预测射频消融术后心房颤动复发:一项荟萃分析。
Europace. 2018 Jan 1;20(1):33-42. doi: 10.1093/europace/eux013.
9
Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation.左心房扩大是非瓣膜性心房颤动患者发生中风和全身性栓塞的独立预测因素。
Sci Rep. 2016 Aug 3;6:31042. doi: 10.1038/srep31042.
10
Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA).肥厚型心肌病患者血栓栓塞风险的预测(HCM风险 - 脑血管意外)
Eur J Heart Fail. 2015 Aug;17(8):837-45. doi: 10.1002/ejhf.316. Epub 2015 Jul 16.